Mineralys Therapeutics
The Director, Compliance plays a central role in building and operationalizing Mineralys' compliance program, reporting to the Vice President of Compliance. This position involves fostering a culture of integrity, managing healthcare professional engagement, and supporting risk-based monitoring and investigations. The role requires deep expertise in pharmaceutical compliance requirements and regulatory standards.
Headquarters
Radnor, Pennsylvania, United States
Company Size
11-50 employees
Founded
2020
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on improving outcomes for people with hypertension, chronic kidney disease (CKD), and cardio-renal-metabolic diseases driven by dysregulated aldosterone. The company's lead investigational candidate, Lorundrostat, is designed to target the underlying role of aldosterone in these conditions. Mineralys is advancing its pipeline through clinical development with the goal of delivering better outcomes for patients inadequately served by current therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mineralys Therapeutics.
23% above the average for this role
Decoding Mineralys Therapeutics Inc (MLYS): A Strategic SWOT Insight
3 days ago
Senior Director, Enterprise Compliance
Oscar Health
Compliance and Ethics Investigator, Consultant
Blue Shield of California
Compliance and Ethics Investigator, Consultant
Blue Shield of California
Director, Compliance
Amplity Health
Global Compliance Program Director
Northeastern University
Director, Compliance
Medical University of South Carolina (MUSC)